| 000 | 01076 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250517232322.0 | ||
| 264 | 0 | _c20190416 | |
| 008 | 201904s 0 0 eng d | ||
| 022 | _a1464-5491 | ||
| 024 | 7 |
_a10.1111/dme.13791 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHerring, R | |
| 245 | 0 | 0 |
_aSGLT2 inhibitors in Type 1 diabetes: is this the future? _h[electronic resource] |
| 260 |
_bDiabetic medicine : a journal of the British Diabetic Association _c12 2018 |
||
| 300 |
_a1642-1643 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xblood |
| 650 | 0 | 4 |
_aEndocrinology _xtrends |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aSodium-Glucose Transporter 2 Inhibitors _xtherapeutic use |
| 700 | 1 | _aRussell-Jones, D L | |
| 773 | 0 |
_tDiabetic medicine : a journal of the British Diabetic Association _gvol. 35 _gno. 12 _gp. 1642-1643 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/dme.13791 _zAvailable from publisher's website |
| 999 |
_c28713694 _d28713694 |
||